STAU2: A Potential Drug Target (G27067)

Target Name: STAU2

NCBI ID: G27067

STAU2: A Potential Drug Target

STAU2 (OTTHUMP00000226836) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and blood vessels. It is a member of the STAU2 family, which is characterized by the presence of a unique catalytic domain called the N -Terminal 伪-helical structure.

STAU2 is involved in a variety of physiological processes in the body, including cell signaling, DNA replication, and response to stress. It has also been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of STAU2 is its potential as a drug target. The N-terminal alpha helix makes it a unique protein that can be targeted by small molecules, such as drugs. Additionally, the protein's involvement in various signaling pathways and its role in disease has made it an attractive target for drug development.

STAU2 has been shown to play a role in a variety of signaling pathways, including the Wnt signaling pathway, the TGF-β pathway, and the NF-kappa-B pathway. Wnt signaling is a critical pathway that regulates cell growth, differentiation, and survival, and is implicated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The TGF-β pathway is a critical pathway that regulates cell growth and differentiation, and is also implicated in a variety of diseases, including cancer, neurodegenerative diseases , and autoimmune disorders. The NF-kappa-B pathway is a signaling pathway that regulates inflammation and immune responses, and is implicated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

STAU2 has also been shown to play a role in DNA replication, which is a critical process for the growth and maintenance of cells. It has been shown to play a role in the regulation of DNA replication in various cell types, including cancer cells, and has been implicated in the development of cancer.

In addition to its role in signaling pathways, STAU2 has also been shown to play a role in stress response. It has been shown to play a role in the regulation of cellular stress responses, and has been implicated in the development of stress-induced diseases , including cancer, neurodegenerative diseases, and autoimmune disorders.

STAU2 has also been shown to play a role in the regulation of inflammation and immune responses. It has been shown to play a role in the regulation of inflammation in various cell types, including cancer cells, and has been implicated in the development of cancer.

In conclusion, STAU2 is a protein that is involved in a variety of physiological processes in the body, including cell signaling, DNA replication, stress response, and inflammation. Its unique N-terminal alpha helix structure and its involvement in various signaling pathways, including Wnt, TGF-β, and NF-kappa-B pathways, make it an attractive target for drug development. Further research is needed to fully understand the role of STAU2 in disease and to develop effective treatments.

Protein Name: Staufen Double-stranded RNA Binding Protein 2

Functions: RNA-binding protein required for the microtubule-dependent transport of neuronal RNA from the cell body to the dendrite. As protein synthesis occurs within the dendrite, the localization of specific mRNAs to dendrites may be a prerequisite for neurite outgrowth and plasticity at sites distant from the cell body (By similarity)

More Common Targets